This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by DeBattista, C. Search for Related Content PubMed PubMed Citation Articles by DeBattista, C. Social Bookmarking                         What's this?

Augmentation and combination strategies for depression

Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA, USA

Treatment-resistant depression represents a common problem, with the vast majority of depressed patients showing incomplete response to antidepressant trials. Augmentation and combination strategies are commonly employed to address this problem, but there are few randomized, controlled studies to guide treatment choice. Indeed, some of the most common augmentation strategies in depression are those with the least controlled evidence. The popularity of bupropion, psychostimulants and atypical antipsychotics as augmentors may not be warranted by existing controlled studies, whereas two less commonly used augmentors-lithium and thyroid hormone- have substantial controlled evidence to support their use. This paper summarizes the state of the evidence for commonly used augmenting strategies and explores preliminary findings for more investigational approaches.

Key Words: augmentation • combination • major depression • treatment-resistant • lithium • thyroid • bupropion • modafinil • glucocorticoid

Journal of Psychopharmacology, Vol. 20, No. 3 suppl, 11-18 (2006)
DOI: 10.1177/1359786806064310


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. Ghanbari, M. El Mansari, and P. Blier Electrophysiological effects of the co-administration of escitalopram and bupropion on rat serotonin and norepinephrine neurons J Psychopharmacol, January 1, 2010; 24(1): 39 - 50. [Abstract] [PDF]

				I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines J Psychopharmacol, June 1, 2008; 22(4): 343 - 396. [Abstract] [PDF]